Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies

Paris C. Papagianis; J. J. Pillow; Timothy J. Moss

doi:10.1016/j.prrv.2018.07.007

Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies

Paris C. Papagianis, J. J. Pillow, Timothy J. Moss

School of Human Sciences

Research output: Contribution to journal › Review article › peer-review

42 Citations (Scopus)

465 Downloads (Pure)

Abstract

Inflammation of the preterm lungs is key to the pathogenesis of bronchopulmonary dysplasia (BPD), whether it arises as a consequence of intrauterine inflammation or postnatal respiratory management. This review explores steroidal and non-steroidal therapies for reducing neonatal pulmonary inflammation, aimed at treating or preventing BPD.

Original language	English
Pages (from-to)	34-41
Number of pages	8
Journal	Paediatric Respiratory Reviews
Volume	30
DOIs	https://doi.org/10.1016/j.prrv.2018.07.007
Publication status	Published - Apr 2019

Access to Document

10.1016/j.prrv.2018.07.007

Papagianis et al., 2019 Bronchopulmonary dysplasia: pathophysiology and potential anti-inflammatory therapiesAccepted author manuscript, 392 KBLicence: CC BY-NC-ND

Cite this

@article{b722a1f887d547bb8da770f3fa570087,

title = "Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies",

abstract = "Inflammation of the preterm lungs is key to the pathogenesis of bronchopulmonary dysplasia (BPD), whether it arises as a consequence of intrauterine inflammation or postnatal respiratory management. This review explores steroidal and non-steroidal therapies for reducing neonatal pulmonary inflammation, aimed at treating or preventing BPD.",

keywords = "Bronchopulmonary dysplasia, Chorioamnionitis, Dexamethasone, Glucocorticoid, Inflammation, Pulmonary",

author = "Papagianis, {Paris C.} and Pillow, {J. J.} and Moss, {Timothy J.}",

year = "2019",

month = apr,

doi = "10.1016/j.prrv.2018.07.007",

language = "English",

volume = "30",

pages = "34--41",

journal = "Paediatric Respiratory Reviews",

issn = "1526-0542",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Bronchopulmonary dysplasia

T2 - Pathophysiology and potential anti-inflammatory therapies

AU - Papagianis, Paris C.

AU - Pillow, J. J.

AU - Moss, Timothy J.

PY - 2019/4

Y1 - 2019/4

N2 - Inflammation of the preterm lungs is key to the pathogenesis of bronchopulmonary dysplasia (BPD), whether it arises as a consequence of intrauterine inflammation or postnatal respiratory management. This review explores steroidal and non-steroidal therapies for reducing neonatal pulmonary inflammation, aimed at treating or preventing BPD.

AB - Inflammation of the preterm lungs is key to the pathogenesis of bronchopulmonary dysplasia (BPD), whether it arises as a consequence of intrauterine inflammation or postnatal respiratory management. This review explores steroidal and non-steroidal therapies for reducing neonatal pulmonary inflammation, aimed at treating or preventing BPD.

KW - Bronchopulmonary dysplasia

KW - Chorioamnionitis

KW - Dexamethasone

KW - Glucocorticoid

KW - Inflammation

KW - Pulmonary

UR - http://www.scopus.com/inward/record.url?scp=85052935106&partnerID=8YFLogxK

U2 - 10.1016/j.prrv.2018.07.007

DO - 10.1016/j.prrv.2018.07.007

M3 - Review article

C2 - 30201135

AN - SCOPUS:85052935106

SN - 1526-0542

VL - 30

SP - 34

EP - 41

JO - Paediatric Respiratory Reviews

JF - Paediatric Respiratory Reviews

ER -

Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies

Abstract

Access to Document

Other files and links

Fingerprint

Cite this